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INTRODUCTION
Electrospinning is a highly versatile technique that enables the production of ultrafine fibers based on polymeric solutions. In recent years, the 
interest in electrospinning has significantly increased 
as the technique provides promising applications in 
many scientific fields (1). A special interest has been 
directed towards applications of electrospun systems 
for drug delivery (2). Electrospun fibers provide unique 
characteristics such as high surface-to-volume ratio, and 
depending on the polymer, tailor-made release kinetics 
for embedded drugs (2, 3). Additionally, electrospinning 
provides the ability to incorporate different types of 
active pharmaceutical ingredients varying in origin, 
physicochemical properties, and molecular size (4). 
Conventional dissolution experiments for drug-loaded 
electrospun fibers are conducted in small vials by 
immersing a preweighed sample in dissolution medium 
at physiological pH and temperature. At predetermined 
time points, defined aliquots are then withdrawn for 
drug quantification and replaced with fresh dissolution 
medium (5). However, this dissolution testing procedure 
is associated with several technical drawbacks. First, 
as the method is not automated, manual sampling is 
required. This creates limitations in terms of the possible 
overall duration of such experiments, and the accuracy of 
data obtained from frequent sampling as required for the 
analysis of rapid drug release processes. Furthermore, as 
the fiber mats are flexible sheet-like structures, irregular 
partial folding or creasing of the mats tends to occur 
when introduced to the aqueous medium. This change 
of conformation may, in turn, affect release kinetics and, 
potentially, the reproducibility of acquired data. 
As an alternative to conventional dissolution testing 
involving the withdrawal of medium aliquots for drug 
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quantification, systems based on optical fibers were 
introduced allowing for continuous in situ sampling 
directly in the dissolution medium (6). Such systems 
allow for the direct UV measurement of dissolved drug 
within samples, and therefore a real-time dissolution 
profile can be obtained (6). The initial report regarding 
the application of such systems for the analysis of drug 
release from tablets was published by Josefson et al. in 
1988 (7). Since then, technical progress has paved the way 
for standardized optical fiber probes with the opportunity 
for the concentration assessment of dissolved drug 
within several individual vessels (8, 9). The automation of 
this process facilitates reproducibility and convenience, 
while the ability to measure concentration accurately 
at high frequency allows for improved detection and 
a better understanding of release kinetics within short 
time frames. However, even though the suitability of such 
a method has already been proven, the assessment of 
release from thin flexible systems like fiber mats provides 
additional challenges. Due to their low weight and large 
surface area, the mats may remain suspended within or 
on the surface of the dissolution medium throughout 
the course of the experiment rather than sinking to the 
bottom of the dissolution vessel, thus distorting reliable 
data acquisition. Furthermore, the aforementioned 
tendency of such sheet-like structures to assume a 
partially folded conformation upon contact with liquids 
is prone to affect the release kinetics of mat-embedded 
drugs.
In this study, we investigated the suitability of a fully 
automated dissolution testing system based on fiber 
optics for in situ monitoring of drug release from 
electrospun fiber mats in comparison with cast films. 
To prevent folding of the fiber mats and films in the 
dissolution medium, we developed an adapter allowing 
for the attachment of the fiber mats and films to the wall 
of the dissolution vessels.
MATERIALS AND METHODS
Materials
Poly(vinyl alcohol) (PVA; Mw 85,000–124,000, >99% 
hydrolyzed) and lysozyme from chicken egg white 
(~70,000 U/mg) were purchased from Sigma–Aldrich 
(Steinheim, Germany). Acetic acid was obtained from 
Fluka (Buchs, Switzerland).
Methods
Fabrication of Electrospun Fiber Mats 
PVA was dissolved in purified water (10% w/v) with acetic 
acid (1% v/v). After adding lysozyme (6% w/w drug/
polymer), the solution was spun using an electrospinning 
setup consisting of a syringe pump system (New Era 
Pump Systems, Inc., USA) and a high voltage power supply 
(Acopian, USA). The polymeric solution was pumped 
through a syringe nozzle with a flow rate of 0.5 mL/h 
while a high voltage of 20 kV was applied. The formed 
electrospun fibers were deposited on a metal collector 
located at a distance of 14 cm from the nozzle. After 
electrospinning, the lysozyme-PVA fibers were stored in 
a desiccator for 24 h before further analysis.
Fabrication of Cast Films
Film-casting was performed by pipetting a defined 
amount of the lysozyme-PVA solution into a Petri dish, 
followed by homogenous distribution of the solution 
on the dish surface. The Petri dishes containing the 
lysozyme-PVA solutions were left at room temperature 
for at least 24 h to ensure complete solvent evaporation 
before being stored in the desiccator.
Fourier-Transform Infrared Spectroscopy
An attenuated total reflectance (ATR) unit was used 
to record Fourier-transform infrared (IR) spectroscopy 
spectra (Spectrometer 400 ATR–IR, Perkin Elmer, USA). 
Spectra of raw substances, cast films, and electrospun 
fibers were collected in the range of 550–4000 cm−1. All 
spectra were recorded at least in triplicate.
Scanning Electron Microscopy 
Samples of the electrospun fibers or cast films were 
mounted on aluminum stubs using double-sided carbon 
discs and sputtered with a thin layer of gold prior to 
analysis (Sputter Coater Q150R ES, Quorum Technologies 
Ltd., UK). The scanning electron microscopy (SEM) 
analysis was performed at an accelerating voltage of 5 kV 
using a Zeiss EVO HD 15 SEM (Carl Zeiss AG, Oberkochen, 
Germany).
In Vitro Drug Release
In vitro drug release experiments were performed 
using an in situ fiber-optic monitoring system, the µDISS 
Profiler, supported by Au PRO software (version 5.1.0.0, 
Pion Inc., Woburn, MA, USA). The fiber-optic probes were 
operated with tips of 20-mm path length. Prior to the 
experiments, each channel was calibrated with its own 
standard curve prepared from multiple additions of a 
fresh solution of lysozyme in phosphate buffered saline 
(PBS) buffer. Punches of electrospun fiber mats and cast 
films were prepared (16-mm diameter), and drug release 
experiments were carried out in 15 mL PBS pH 7.4 at 
37 °C with magnetic stirring at 100 rpm. UV absorption 
(280 nm) was measured at a time interval of 10 sec for 
the first 5 min, followed by measurements at 30-sec 
intervals for the following 10 min. After this initial period, 
measurements were performed every 60 sec. Release 
experiments were performed at least in triplicate. 
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RESULTS AND DISCUSSION
Fabrication and Characterization of 
Electrospun Fibers and Cast Films
To investigate the applicability of an in situ fiber-
optic monitoring system for testing drug release from 
electrospun fibers, lysozyme was used as a model drug 
and encapsulated within electrospun fibers based on 
PVA. For comparison, cast films based on the same 
solution used for electrospinning were prepared. Despite 
the identical composition of both polymeric systems, 
a clear difference in the visual appearance could be 
noticed. The electrospun fiber mats exhibited an opaque 
white color (Figure 1A) that can be attributed to the 
ultrafine substructure of the fiber network (Figure 1B) 
(10). In contrast, the cast films appeared transparent 
with a smooth surface (Figure 1C,D). Both samples were 
prepared as circular punches with the same diameter and 
therefore the same apparent surface area. However, the 
ultrafine substructure of the electrospun fibers (individual 
fiber diameters approximately 500 nm) increases the 
actual surface area of these samples, which can be 
expected to have an impact on the release kinetics of 
embedded drugs.
To elucidate any potential chemical interactions as a result 
of sample fabrication, ATR–IR spectra of pure compounds, 
fiber mats, and cast films were acquired. When comparing 
the ATR–IR spectra of the pure compounds to the spectra 
of the drug-loaded systems, neither the appearance of 
novel peaks nor the extinction of initial peaks (indicative 
of a chemical interaction as a result of sample preparation 
or instability) occurred (Figure 2). Further, comparison of 
the spectra of films and fiber mats does not reveal any 
differences due to the respective fabrication technique. 
In addition, the incorporation of lysozyme into the fibers 
as well as into the films can be detected by the amide I 
peak (1650 cm-1). 
Figure 1. (A) Surface morphology of the electrospun ﬁbers, 
(B) SEM image of the electrospun ﬁbers, (C) surface morphology
of a cast ﬁlm, (D) SEM image of a cast ﬁlm.
 
Figure 2. ATR–IR spectra of pure compounds, electrospun
ﬁber mats, and cast ﬁlms.
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Conventional Release Experiments with 
Electrospun Fibers
Conventional drug release experiments are performed 
by immersing the drug-loaded dosage form in buffer 
and quantifying the concentration of the released drug 
at predetermined time points. Although thin polymeric 
dosage forms such as electrospun fiber mats, films, or 
transdermal patches can potentially be investigated 
using this method, the thin and flexible structure of these 
dosage forms make them susceptible to folding upon 
immersion in the release medium as illustrated in Figure 
3. This folding process is likely to decrease the surface 
area of the investigated sample, leading to inaccurate 
assessments of the release kinetics. 
This phenomenon necessitates the preservation of 
the flat structure of the sample during the release 
experiment for improved accuracy and reproducibility. 
Indeed, dissolution testing for transdermal patches as 
described in the pharmacopeia (11) requires the fixation 
of the sample by using a strip of double-sided adhesive 
tape or an extraction cell. The same concept has been 
presented for polymeric films (12, 13). For electrospun 
fibers, however, drug release experiments are generally 
conducted by simply immersing the fiber mats in buffer 
without any fixation of the sample (5), even though there 
are few reports where the issue of sample folding was 
addressed. For instance, a modified Finn chamber was 
used for investigating drug release from electrospun 
fibers, hence keeping the sample from folding during 
the release experiments (14). In the present study, a 
novel flexible adapter was designed. The aim was to 
keep the sample fixed in a certain position during the 
release study, thus preventing migration and folding. 
The designed adapter was composed of commercially 
available silicone and a nylon-based net (Figure 4). The 
mechanical flexibility of silicone allowed for convenient 
use, while the net provided a suitable support and, at the 
same time, unrestricted diffusion of the release medium 
and released drug. Prior to the release experiments, 
interactions of net material and drug were experimentally 
excluded (data not shown).
In Vitro Drug Release with the Fiber-Optic System
Release experiments in PBS pH 7.4 were performed with 
the electrospun fiber mats as well as with the cast films. 
The samples were mounted using the designed adapter, 
which assured holding the sample flat in position and 
prevented undesired sample folding (Figure 4). During 
the experiment, the dissolution vials were tightly sealed 
to prevent volume change due to medium evaporation. 
Each fiber-optic channel (corresponding to a separate 
dissolution vessel) was calibrated with its own standard 
curve prior to experimentation, and a very good linearity 
was achieved as shown in the representative calibration 
curve (Figure 5A). The theoretical drug content in the fiber 
mats and films was calculated based on the solid mass of 
lysozyme compared with the solid mass of the polymer. 
Thus, solvent evaporation upon electrospinning (or film 
casting) did not affect the lysozyme/polymer mass ratio. 
These calculations were successfully proofed by drug 
content analysis after destroying fiber mats and films. 
Complete drug release from the electrospun fibers as well 
as from the cast films was observed after approximately 
20 min, which can be expected due to the hydrophilic 
nature of the drug and the polymeric fiber material. The 
results of the release experiments are shown in Figure 
5B, and the data are represented as mean ± SD (n = 3). 
Figure 3. Electrospun ﬁber mat with a glass vial for conventional
drug release testing before immersion in dissolution medium and
in dissolution medium (magniﬁcation).
Figure 4. Sample mounting using the designed ﬂexible adapter.
(A) Adapter without (top) and with (bottom) electrospun mat; 
(B) adapter with ﬁber mat installed within the dissolution vessel.
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The frequent sampling intervals provided a deeper insight 
into the release process from the electrospun fibers as 
well as from the cast films. In this context, we can see 
that lysozyme was released faster from the electrospun 
fibers than from the cast films (Figure 5B). This can be 
attributed to the higher surface area provided by the 
ultrafine fibrous structure, which facilitated the release 
of lysozyme into the dissolution medium. Although the 
overall difference in the release kinetics can be considered 
marginal, the identification of this occurrence could be 
achieved successfully. 
CONCLUSION
Fully automated fiber-optic systems provide many 
advantages for the dissolution testing of electrospun 
fibers as the high sampling frequency made possible 
by the in situ fiber optics allows for a deeper insight 
into release kinetics. Further, the adapter designed in 
the current work provided the required support for the 
tested samples and prevented the undesired sample 
folding. The present study highlights the potential of 
applying fiber-optic dissolution systems for investigating 
drug release from electrospun fiber mats, thus providing 
an advanced alternative to the conventional dissolution 
experimental setups.
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